Effects of benzophenanthridine alkaloids on the phosphorylation of an ∼44 kDa protein present in a mitochondrial fraction of the rat heart

Biochemical Pharmacology

Volumn 51, Issue 2, 1996, Pages 151-157

  Lombardini, John B ^a,b   Props, Cristi ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

Author keywords

Chelerythrine; Mitochondria; Protein phosphorylation; Rat heart; Sanguinarine; Taurine

Indexed keywords

ALKALOID; BENZOPHENANTHRIDINE DERIVATIVE; CHELERYTHRINE; DITHIOTHREITOL; GLUTATHIONE; REDUCING AGENT; SANGUINARINE; TAURINE;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ANTAGONISM; HEART MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT;

EID: 0030031338     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-2952(95)02166-3     Document Type: Article

References (24)

1. Stermitz FR, Gillespie JP, Amoros LG, Romero R, Stermitz TA, Larson KA, Earl S and Ogg JE, Synthesis and biological activity of some antitumor benzophenanthridinium salts. J Med Chem 8: 708-713, 1975.
2. Mitscher LA, Park YH, Clark D, Clark GW III, Hammesfahr PD, Wu WN and Beal JL, Antimicrobial agents from higher plants. An investigation of Hunnemannia fumariaefolia pseudoalcoholates of sanguinarine and chelerythrine. Lloydia 41: 145-150, 1978.
3. Lenfeld J, Kroutil M, Maršálek E, Slavík J, Preininger V and Šimánek V, Antiinflammatory activity of quaternary benzophenanthridine alkaloids from Chelidonium jamus. Planta Med 43: 161-165, 1981.
4. Walterová D, Ulrichová J, Preininger V, Šimánek V, Lenfeld J and Lasovskỳ J, Inhibition of liver alanine aminotransferase activity by some benzophenanthridine alkaloids. J Med Chem 24: 1103-1107, 1981.
5. Cohen HG, Seifen EE, Straub KD, Tiefenback C and Stermitz FR, Structural specificity of the NaK-ATPase inhibition by sanguinarine, an isoquinoline benzophenanthridine alkaloid. Biochem Pharmacol 27: 2555-2558, 1978.
6. Herbert JM, Augereau JM, Gleye J and Maffrand JP, Chelerythrine is a potent and specific inhibitor of protein kinase C. Biochem Biophys Res Commun 172: 993-999, 1990.
7. Barg J, Belcheva MM and Coscia CJ, Evidence for the implication of phosphoinositol signal transduction in μ-opioid inhibition of DNA synthesis. J Neurochem 59: 1145-1152, 1992.
8. Ko F-N, Chen I-S, Wu S-J, Lee L-G, Haung T-F and Teng C-M, Antiplatelet effects of chelerythrine chloride isolated from Zanthoxylum simulans. Biochim Biophys Acta 1052: 360-365, 1990.
9. Kozak W, Klir JJ, Conn CA and Kluger MJ, Inhibitors of protein kinase C attenuate fever and potentiate antipyretic effect of dexamethasone in rats. FASEB) 9: A645, 1995.
10. Lombardini JB, Paradoxical stimulatory effect of the kinase inhibitor chelerythrine on the phosphorylation of a ∼20 K Mr protein present in the mitochondrial fraction of rat retina. Brain Res 673: 194-198, 1995.
11. Lombardini JB, Partial characterization of an ∼20 K M, retinal protein whose phosphorylation is inhibited by taurine. Biochem Pharmacol 46: 1445-1451, 1993.
12. Lombardini JB, Effects of taurine on protein phosphorylation in mammalian tissues. In: Taurine, Nutritional Value and Mechanisms of Action (Eds. Lombardini JB, Schaffer SW and Azuma J), pp. 309-318. Plenum Press, New York, 1992.
13. Lombardini JB, The inhibitory effects of taurine on protein phosphorylation: Comparison of various characteristics of the taurine-affected phosphoproteins present in rat retina, brain and heart. In: Taurine in Health and Disease (Eds. Michalk DV and Huxtable RJ), pp. 9-17. Plenum Press, New York, 1994.
14. Lombardini JB, Effects of taurine and taurine analogues on the phosphorylation of a 44 kDa protein present in a mitochondrial subfraction of the rat heart: Partial characterization of the 44 kDa phosphoprotein. J Mol Cell Cardiol 26: 1675-1689, 1994.
15. Laemmli UK, Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685, 1970.
16. Chou T-C and Talalay P, Quantitative analysis of dose-effect relationships: The combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul 22: 27-55, 1984.
17. Chou T-C and Talalay P, Applications of the median-effect principle for the assessment of low-dose risk of carcinogens and for the quantitation of synergism and antagonism of chemotherapeutic agents. In: New Advances in Developmental Cancer Therapy, Bristol-Meyers Cancer Symposia (Eds. Harrap KR and Conners TA), pp. 37-64. Academic Press, New York, 1986.
18. Lombardini JB, Effects of taurine on calcium ion uptake and protein phosphorylation in rat retinal membrane preparations. J Neurochem 45: 268-275, 1985.
19. Li Y-P and Lombardini JB, Taurine inhibits the phosphorylation of two endogenous proteins (M, ∼140 and ∼20 K) in subcellular preparations of rat cortex. Neurochem Int 17: 389-399, 1990.
20. 2 fraction. J Neurochem 56: 1747-1753, 1991.
21. Li Y-P and Lombardini JB, Inhibition by taurine of the phosphorylation of specific synaptosomal proteins in the rat cortex: Effects of taurine on the stimulation of calcium uptake in mitochondria and inhibition of phosphoinositide turnover. Brain Res 553: 89-96, 1991.
22. Sturman JA and Gargano AD, Phosphorylation of cat cortical membranes in vitro during development: Effects of taurine. Pharmacol (Life Sci Adv) 9: 595-602, 1990.
23. Lombardini JB and Liebowitz SM, Taurine modifies calcium ion uptake and protein phosphorylation in rat heart. In: Taurine and the Heart (Eds. Iwata H, Lombardini JB and Segawa T), pp. 117-137. Kluwer Academic Publishers, Boston, MA, 1989.
24. Schaffer SW, Allo S, Harada H and Azuma J, Regulation of calcium homeostasis by taurine: Role of calmodulin. In: Functional Neurochemistry, Physiology, and Cardiology (Eds. Pasantes-Morales H, Martin DL, Shain W and Martin del Rio R), pp. 217-225. Wiley-Liss, New York, 1990.